Member Directory

Opthea Limited

Member Contact: Dr Megan Baldwin

Position: Founder & Chief Innovation Officer

Industry: Biotech & Pharmaceuticals

Company Profile:

Opthea Limited (NASDAQ: OPT, ASX: OPT) is a global biopharmaceutical company aspiring to become the leader of therapeutic innovation in retinal diseases.

We started with a vision of the future, where the impact of retinal disease is reduced, and patients’ quality-of-life is enhanced. With people as our focus, we assembled a world-class team of ophthalmology experts in pursuit of breakthrough therapies. Together we focused on scientific innovation for those who suffer from retinal disease. Today, we are translating our discoveries into promising new medicines.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria, the Bunurong, Eastern Maar, Gunaikurnai, Wadawurrung and Wurundjeri Woi-wurrung peoples, on which BioMelbourne Network lives and works. We pay respect to their Elders past and present. We acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.